Quintiles and SP Pharmaceuticals Collaborate to Provide Complete Drug Development Services
Under the agreement, Quintiles has named SP Pharmaceuticals its preferred provider for contract manufacturing of sterile injectable products and will market SP Pharmaceuticals to customers seeking those services. Likewise, SP Pharmaceuticals has named Quintiles its preferred provider of comprehensive clinical trial services and will market Quintiles to customers seeking those services.
"This agreement allows us to offer our clients a more complete package of services and a more seamless development process," said Mike Baltezor, vice president of Quintiles Preclinical & Pharmaceutical Sciences. "The top-quality focus of both our companies has given us an excellent working relationship in the past and we are excited to solidify this relationship even further."
SP Pharmaceuticals is a contract manufacturer and developer of sterile pharmaceutical products. The company specializes in small-volume, liquid, and lyophilized parenterals (injectable drugs).
Combining SP Pharmaceuticals' strengths in sterile dosage form manufacturing and development with Quintiles' strengths in compound selection, development, clinical testing, data management, registration, and commercialization, should accelerate the development, registration, and launch process for sterile drug products, both companies said.
"This collaborative agreement gives customers greater control, with more convenience, over a wider range of services than has previously existed," said Art Solomon, SP Pharmaceuticals' vice president of business development.
About SP Pharmaceuticals
N/A is a contract manufacturer and developer of small-volume (SVPs), liquid and lyophilized sterile drug products. SP Pharmaceuticals offers customers a complete range of services including pharmaceutical formulation and development, regulatory assistance, and production of clinical supply and commercial product batches. The company's quality control program supports its customers' efforts in obtaining in approvals from the U.S. Food and Drug Administration and worldwide regulatory agencies.
About Quintiles
Quintiles Transnational Corp. improves healthcare by bringing new medicines to patients faster and providing knowledge-rich medical and drug data to advance the quality and cost effectiveness of healthcare. Quintiles is the global market leader in helping pharmaceutical, biotechnology and medical device companies develop and sell their products; the company also provides insightful market research solutions and strategic analyses to support healthcare decisions. Quintiles employs a global workforce operating from offices in 31 countries. Quintiles Transnational is a member of the S&P 500, Fortune 1000 and Nasdaq 100.